Guru Ownership Trend
Guru Analysis for Enanta Pharmaceuticals, Inc. (ENTA)
Enanta Pharmaceuticals, Inc. (ENTA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.03 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.52 M net outflow during the quarter.
On the selling side, Cliff Asness reduced exposure by 18.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Enanta Pharmaceuticals, Inc. (ENTA)
Major holders include Renaissance Technologies (RenTech) ($8.13 M), Cliff Asness ($3.75 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 814,470 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.52 M, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ENTA. The total reported sell value was $2.52 M.
No tracked managers opened new positions or increased their holdings in ENTA during the most recent reporting period.